US healthcare spending is set to rise 7.1% in 2025. That's faster than inflation and the economy. The surge sharpens pressure on payers and budgets.
Why spending will keep rising
The Centers for Medicare & Medicaid Services projects a 7.1% increase in healthcare expenditures in 2025, followed by an average annual rise of 5.8% through 2033, according to CMS projections.
These numbers are important for both investors and public budgets.
They show health costs are likely to outpace general price growth and gross domestic product expansion, forcing insurers, state programmes and employers to confront bigger deficits and tighter margins. Payers are already feeling that heat: cost containment has moved from a back‑office priority to a boardroom imperative.
That pressure is partly why prevention has re-entered policy conversations. If chronic illness drives much of the spending growth, then reducing its incidence, or delaying its onset, becomes a core financial strategy — not just a clinical one.
Technology’s role: messy now, promising later
At present, many payers can't see the full picture. A survey cited by industry observers found 96% of payers rely on multiple separate software tools to manage payment integrity, creating fragmented workflows and lots of manual work.
That fragmentation raises administrative costs and increases the chance of pricing errors or missed compliance updates.
The problem is that adding more separate solutions costs a lot. Gartner describes a different approach: composable architecture, where modular applications plug into a unified, cloud‑based ecosystem. In such a setup, claims can be ingested, adjudicated, routed and priced within the same end‑to‑end process.
That means consistent pricing rules, fewer handoffs and a smaller window for cascading errors when one system isn’t updated. Human specialists would still handle complex cases, but routine checks could be automated and centrally governed, improving both speed and accuracy.
AI adoption remains limited — and it's a missed lever
Even though automation could cut costs, adoption is uneven. Industry data shows only 23% of payers currently use artificial intelligence to automate processes or assess claims accuracy. That's low, given the potential upside.
Why the delay? It's partly due to old systems, isolated data, and cautious attitudes. Payers often juggle legacy systems that aren’t designed to share data easily, making AI projects costly and fragile.
There’s also a governance issue. Machine learning models that touch claims need clear audit trails and explainability; payers and regulators demand that. Where composable platforms are in place, those requirements become easier to meet because the system enforces consistent rules and logging.
Prevention: cheap ideas, complex financing
Prevention can look deceptively simple and cheap. Dr Mehmet Oz, described in a recent interview as the Centres for Medicare & Medicaid Services Administrator, argued small lifestyle changes could cut healthcare bills substantially. "If we get the average person right now walking around New York to eat a little better today and just walk 10, 15 minutes a day, that saves us a ton of money," he said.
His point is familiar to public health specialists: modest behaviour changes can reduce the prevalence of chronic conditions that drive long‑term costs. But turning that public‑health logic into bankable savings is tricky.
Paying for prevention requires upfront spending on programmes, staff and data systems, while the savings often arrive over years and across different payers. Employers pick up some costs; state Medicaid programmes pick up others. Because the savings spread out across different payers, many hesitate to invest despite the overall benefits.
Local innovation and the value‑based turn
Conversations at regional forums underline a shift in strategy. The Orange County Business Journal’s Healthcare Roundtable highlighted executives and health‑plan leaders emphasising preventive and value‑based care, better use of data, and greater coordination between providers and payers.
Those conversations reflect a broader trend: hospitals and insurers are trying to move away from fee‑for‑service models toward arrangements that reward keeping people well. That requires measurement — and measurement requires integrated systems.
Where composable platforms and better data flows are in place, organisations can track outcomes, attribute savings and design contracts that share risk and reward. Where they’re not, payers still fight for every percentage point on price rather than building programmes that reduce demand.
What it means for investors and public budgets
For investors, the growth in healthcare spending points to continued revenue opportunities across services and technology. Vendors that simplify claims processing, provide reliable analytics, or offer verified prevention programmes could win market share as payers hunt for efficiency.
For public budgets, the arithmetic is harsher. Faster healthcare cost growth compounds fiscal pressure at the state and federal level. Some states already report higher Medicaid bills per resident; waste and fraud are often cited as partial drivers, alongside demographic trends.
Governments face a choice: tighten eligibility and benefits, shift costs to employers and households, or invest in systems and preventive measures that may yield net savings over time. Each path has political and distributional consequences.
How payers might bridge the gap
Bridging the gap means two things together: smarter spending on prevention and better technology to capture savings. Preventive programmes must be measurable and tied to financial outcomes, not just clinical metrics. And technology needs to support that measurement — linking interventions to claims data and outcomes across time.
Adopting composable, interoperable platforms can help. They reduce the friction of integrating new tools, make rules consistent and let organisations scale pilots without rebuilding their whole stack. When a prevention pilot shows savings, the payer can apply the same logic across populations more quickly.
Thing is, AI can accelerate that work, but only if data governance and explainability are addressed up front. Where models adjudicate claims or predict risk, regulators will expect transparency; the path of least resistance is a platform that enforces consistency and auditability.
Bottom line for markets
Investors should watch who's delivering measurable cost reductions, not just flashy pilots. Vendors that help payers cut administrative waste, standardise pricing and measure prevention impact will be valued more highly.
And for policymakers, the choice is clear in fiscal terms: accept faster spending growth, or back integrated programmes and platforms that make prevention and payment integrity work at scale.
Related Articles
The Centers for Medicare & Medicaid Services projects a 7.1% rise in healthcare spending in 2025.
This article was created with AI assistance.
